Related Experiment Video
Updated: Jan 18, 2026

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways
Published on: December 13, 2024
Pulmonary Fungal Infections in the Immunocompetent Host.
Anthony Lieu1, Jordan K Mah2, Donald C Vinh3
1Department of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, BC, Canada; Department of Pathology, Division of Medical Microbiology, University of British Columbia, Vancouver, BC, Canada.
Pulmonary fungal infections are rising in immunocompetent individuals due to environmental and medical factors. Early diagnosis requires high suspicion and integrated testing, as non-invasive biomarkers have limitations.
Area of Science:
- Pulmonology
- Mycology
- Infectious Diseases
Background:
- Pulmonary fungal infections are increasingly seen in immunocompetent individuals, driven by climate change, post-viral syndromes, and intensive care practices.
- While immunocompetent hosts usually fight off fungal infections, severe disease can occur with lung abnormalities, temporary immune issues, or hypersensitivity.
Purpose of the Study:
- To highlight the challenges in diagnosing pulmonary fungal infections in immunocompetent hosts.
- To emphasize the need for a comprehensive approach integrating risk factors and diagnostic tools.
Main Methods:
- Review of current understanding of pulmonary fungal infections in immunocompetent individuals.
- Analysis of diagnostic challenges and limitations of biomarkers like serum galactomannan and (1-3)-ß-D-Glucan.
- Discussion of the necessity for invasive sampling and limitations of conventional testing.
Main Results:
- Low clinical suspicion often accompanies fungal infections in immunocompetent hosts due to a lack of traditional risk factors.
- Nonspecific symptoms and unclear radiographic findings complicate early recognition.
- Non-invasive biomarkers have limited sensitivity in this population, often necessitating invasive sampling and slow, insensitive conventional testing.
Conclusions:
- Accurate and timely diagnosis of pulmonary fungal infections in immunocompetent individuals requires a high index of suspicion and appropriate diagnostic strategies.
- An integrated clinical approach combining epidemiological data, novel risk factors, and an understanding of diagnostic test limitations is crucial for effective management.
More Related Videos
09:52Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
06:43Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
Published on: January 13, 2016
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Fungal Phylum Microsporidia
Other Pulmonary Disorders
Fungal Group Zygomycota